Celebrating First-Time Disclosers & First-Time Lead Inventors
The Office of Technology Transfer and Innovation (OTTI) is proud to recognize members of the University of Houston community who have taken an important step in turning research and creative scholarship into real-world impact. Submitting an intellectual property disclosure helps protect ideas, opens pathways to licensing and commercialization, and supports UH’s mission to translate innovation into societal benefit.
First-Time Disclosers
First-time disclosers are inventors, authors, or contributors who have submitted their first intellectual property disclosure to OTTI. This recognition celebrates individuals who are engaging with the innovation and commercialization process for the first time and helping build UH’s culture of research impact. The UH disclosure process is the only formal starting point for OTTI evaluation and potential protection of patents, copyrights, know-how, and other intellectual property.
First-Time Lead Inventors
First-time lead inventors are individuals serving as the primary inventor/contact on a disclosure for the first time. This recognition highlights faculty, staff, postdocs, and students who are taking a leading role in advancing an invention through the UH innovation process. The disclosure form identifies a primary investigator/contact for the disclosure and captures inventor contributions to support evaluation and protection decisions.
Why Disclose?
Disclosing your invention or creative work to OTTI can help you:
- Protect your intellectual property through patents, copyrights, and related strategies.
- Receive recognition for your contributions to your field and the university.
- Create opportunities for commercialization, licensing, and industry collaboration.
- Support compliance with university and funding requirements.
OTTI encourages inventors to submit a disclosure before any public disclosure, including a publication, presentation, grant application, poster, or discussion outside the university. UH’s commercialization guidance recommends submitting a disclosure at least three months before public disclosure and advises against discussing inventions outside UH without appropriate confidentiality protections such as an NDA.
UH Employees’ Duty to Disclose
Under UH’s intellectual property framework, the purpose of the OTTI disclosure form is to notify the university of intellectual property in compliance with UH System Board of Regents Policy 21.08. The System’s OTTI is responsible for the custody, management, and licensing of intellectual property assets created within the UH System, and Board Policy 21.08 provides that the Board owns intellectual property rights for technology conceived or reduced to practice by persons engaged in System research, subject to the policy’s terms.
In practical terms, if you are a UH employee and believe you have developed a potentially protectable invention, software, copyrighted work, know-how, or other intellectual property connected to your university work, you should disclose it to OTTI so the university can evaluate protection, ownership, sponsorship obligations, and commercialization options.
Submit a Disclosure
Ready to disclose? Please use the current UH disclosure form:
Intellectual Property Disclosure Form
After completing the form, email the signed disclosure to oipm@central.uh.edu. UH advises using the latest version of the form and allowing 60–90 days for a full evaluation.
Need Help? Join Drop-In Disclosure Office Hours
Have questions about whether your work should be disclosed, how to complete the form, inventorship, sponsorship obligations, public disclosure timing, or commercialization potential? Join OTTI’s online drop-in disclosure office hours for informal guidance and Q&A.
Drop-in disclosure office hours:
Thursday, 1 – 2pm CT (Weekly)
Microsoft Teams (Online)
Meeting ID: 240 357 514 011 21
Passcode: 8TM2Uy3D
2026 Q1 First-Time Disclosers
*First-Time Lead Inventor
| Name | Affiliation |
|---|---|
| Wei Guo* | Pharmacology and Pharmaceutical Science, Pharmacy |
| Dan Wang | Pharmacology and Pharmaceutical Science, Pharmacy |
| Ines Guerra Varela | New Jersey Institute of Technology |
| Beshoy Sefen | New Jersey Institute of Technology |
| Jongsang Son* | New Jersey Institute of Technology |
| Seuong Hoon Park | Health and Human Performance, Liberal Arts and Social Sciences |
| Marina Samuel | New Jersey Institute of Technology |
| Sophia Starzynski | New Jersey Institute of Technology |
| Jiaming Zhang | Electrical and Computer Engineering, Engineering |
| Yuan Yin | Pharmacology and Pharmaceutical Science, Pharmacy |
| Luona Yang | Pharmacology and Pharmaceutical Science, Pharmacy |
| Nipun Sutradhar | Mechanical and Aerospace Engineering, Engineering |
| Muhammad Noman Rahman* | Mechanical and Aerospace Engineering, Engineering |
| Md Shajedul Hoque Thakur | King Fahd University of Petroleum and Minerals (KFUPM) |
| Ravi Jada | Mechanical Engineering |
| Tetiana Kolodiazhna | Pharmacology and Pharmaceutical Science, Pharmacy |
| Ruslan Rafikov | Indiana University Bloomington |
| Dinesh Bharti | Indiana University Bloomington |
| Paul Byaruhanga | Physics, Natural Science and Mathematics |
| Shuo Chen* | Physics, Natural Science and Mathematics |
| Mohamed Elanany | Saudi Aramco Technology Company (SATC) |
| Trang Le nu Nuyen | Pharmacology and Pharmaceutical Science, Pharmacy |
| Finn Beruldsen* | Department of Biology and Biochemistry |
| Guoning Chen* | Natural Science and Mathematics, Natural Science and Mathematics, Center for Nuclear Receptors and Cell Signaling |
| Muhammad Naeem Akram | Natural Science and Mathematics |
2026 Q2 First-Time Disclosers
*First-Time Lead Inventor
| Name | Affiliation |
|---|---|
| Suparna Ghosh | Department of Pharmacological & Pharmaceutic Sciences, Pharmacy |
| Jason Franco-Castano | Department of Pharmacological & Pharmaceutic Sciences, Pharmacy |
| Mohamed Behery | Department of Pharmacological & Pharmaceutic Sciences, Pharmacy |
| Victoria Mgbemena | Prairie View A&M University |
| Joseph Lane | Department of Chemical and Biomolecular Engineering, Engineering |
| Onkar Ghangrekar | Department of Chemical and Biomolecular Engineering, Engineering |
| Rahul Pandey | SRI |
| Yongqi Xiao | Department of Pharmacological & Pharmaceutic Sciences, Pharmacy |
| Abhishek Roy | Department of Biomedical Engineering, Natural Science and Mathematices |
| Abishek Mishra | Department of Biomedical Engineering, Natural Science and Mathematics |
| Madhan Tirumalai* | Department of Biomedical Engineering, Natural Science and Mathematics |
| Robert Johnson* | Buisness, Small Buisness Development Center |
| Cynthia Roberts* | Ohio State University |
| Yuncheng Du* | Department of Biomedical Engineering, Engineering |
| Vivek Kumar* | Department of Biomedical Engineering, Engineering, Natural Science and Mathematics |
| Michael Kalloniatis* | Clinical Science, Optometry |
| Jack Phu | Clinical Science, Optometry |
| Marino Guro | Clinical Science, Optometry |
| Maggie Zhang | Clinical Science, Optometry |
| Nana Adams | Department of Vision Sciences, Optometry |
| Yun Wan* | Univeritsy of Houston Downtown, Business |
| Yoram Kalman | The Open University of Israel |
| Elham Morshedzadeh | Department of Industrial Design, Architecture |
| Paige Willson | School of Theatre & Dance, Arts |
| Elena Grassi | Electrical and Computer Engineering, Engineering |
| Aime Aguilar-Herrera | Electrical and Computer Engineering, Engineering |
| Shantanu Sarkar | Electrical and Computer Engineering, Engineering |
| Sarai Marisol Juarez Uribe | Mechanical Engineering, Engineering |
| Asael Andrade | Mechanical and Aerospace Engineering, Engineering |
| Alexis Javier Oliva Martinez | Mechanical Engineering, Engineering |
| Christopher Arellano | University of Arizona |
| Weiyi Peng* | Department of Biology and Biochemistry, Natural Science and Mathematics, Center for Nuclear Receptors and Cell Signaling |
| Jiakai Hou | Department of Biology and Biochemistry, Natural Science and Mathematics, Center for Nuclear Receptors and Cell Signaling |
| Ningbo Zheng | Department of Biology and Biochemistry, Natural Science and Mathematics, Center for Nuclear Receptors and Cell Signaling |
| Chun He | University of Chicago |
| Cheng-Wei Ju | University of Chicago |
| Fanfei Meng | Department of Pharmacological & Pharmaceutic Sciences, Pharmacy |
| Cao Thuy giang Nguyen | University of Massachusetts at Lowell |